Cargando…
Effect of tamoxifen upon cell DNA analysis by flow cytometry in primary carcinoma of the breast.
The effect of tamoxifen upon cellular DNA ploidy in carcinoma of the breast was assessed by flow cytometry (FCM), in a prospective group of 77 patients with primary operable disease. Each had a needle biopsy at the outpatient visit for diagnosis and FCM analysis, and definitive surgery was performed...
Autores principales: | Baildam, A. D., Zaloudik, J., Howell, A., Barnes, D. M., Moore, M., Sellwood, R. A. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1987
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2001732/ https://www.ncbi.nlm.nih.gov/pubmed/3606948 |
Ejemplares similares
-
DNA analysis by flow cytometry, response to endocrine treatment and prognosis in advanced carcinoma of the breast.
por: Baildam, A. D., et al.
Publicado: (1987) -
Investigating differences between tamoxifen resistant and sensitive breast cancer cells with flow cytometry
por: Bitton, Aric, et al.
Publicado: (2021) -
A controlled trial of adjuvant tamoxifen, with or without prednisolone, in post-menopausal women with operable breast cancer.
por: Fentiman, I. S., et al.
Publicado: (1994) -
The prognostic significance of DNA flow cytometry in breast cancer: results from 881 patients treated in a single centre.
por: Camplejohn, R. S., et al.
Publicado: (1995) -
Tamoxifen evolution
por: Howell, A., et al.
Publicado: (2023)